GlassScriptPhysician profile
Rafaela M Aguiar
NPI 1679599096
$2,536.03
in general payments reported to CMS, 2019-2025
22 companies · $1,049 in 2025
The $1,049 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $347 · 2023: $681 · 2024: $459 · 2025: $1,049.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,189.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $980.87 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $404.50 | 2023-2025 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $240.70 | 2023 | Benlysta, Arexvy |
| Lilly USA, LLC | $175.69 | 2023-2025 | Mounjaro |
| Comsort, INC | $100.00 | 2019 | |
| Pfizer INC. | $91.49 | 2025 | |
| Abbvie INC. | $83.91 | 2025 | |
| Corcept Therapeutics | $56.33 | 2025 | Korlym |
| Otsuka America Pharmaceutical, INC. | $50.01 | 2025 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $45.15 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $43.30 | 2025 | Caplyta |
| Abbott Laboratories | $36.95 | 2025 | Freestyle Libre 3 |
| Astellas Pharma US INC | $36.46 | 2025 | Veozah |
| Sumitomo Pharma America, INC. | $27.09 | 2025 | Gemtesa |
| Lundbeck LLC | $26.95 | 2025 | Rexulti |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynavax Technologies Corporation | $23.11 | 2025 | Heplisav-B |
| Grifols USA, LLC | $22.77 | 2025 | Prolastin-C Liquid |
| Exact Sciences Corporation | $21.12 | 2025 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $20.38 | 2025 | Aptima, Thinprep 2000 Processor |
| Vanda Pharmaceuticals INC. | $19.57 | 2025 | Hetlioz, Fanapt |
| Amgen INC. | $16.01 | 2025 | Evenity |
| Inspire Medical Systems, INC. | $13.67 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafaela Aguiar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.